L. E. Nimmo

405 total citations
10 papers, 312 citations indexed

About

L. E. Nimmo is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, L. E. Nimmo has authored 10 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in L. E. Nimmo's work include Cardiovascular Effects of Exercise (4 papers), Cardiac Fibrosis and Remodeling (3 papers) and Cardiovascular Function and Risk Factors (3 papers). L. E. Nimmo is often cited by papers focused on Cardiovascular Effects of Exercise (4 papers), Cardiac Fibrosis and Remodeling (3 papers) and Cardiovascular Function and Risk Factors (3 papers). L. E. Nimmo collaborates with scholars based in United States. L. E. Nimmo's co-authors include F. C. White, Eric Breisch, C. M. Bloor, Gregory M. Marcus, M. Dan McKirnan, Michael F. Ball, Gordon A. Ewy, Bertron Μ. Groves, Barbara Jackson and Colin M. Bloor and has published in prestigious journals such as Circulation, Journal of Applied Physiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

L. E. Nimmo

10 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. E. Nimmo United States 9 200 62 50 48 37 10 312
Tsutomu Iwasaki Japan 11 265 1.3× 84 1.4× 50 1.0× 109 2.3× 60 1.6× 29 463
Paraschos Geleris Greece 11 272 1.4× 44 0.7× 73 1.5× 48 1.0× 65 1.8× 26 435
F Rauscha Austria 10 180 0.9× 40 0.6× 81 1.6× 41 0.9× 58 1.6× 34 350
Jason D. Stoner United States 8 155 0.8× 46 0.7× 60 1.2× 21 0.4× 28 0.8× 12 333
Sumiyo Yamashita Japan 12 189 0.9× 54 0.9× 63 1.3× 33 0.7× 55 1.5× 36 364
Clarito Dimayuga United States 6 334 1.7× 58 0.9× 89 1.8× 29 0.6× 86 2.3× 7 475
Yuri Belenkov Russia 8 381 1.9× 75 1.2× 88 1.8× 40 0.8× 31 0.8× 15 493
Tsutomu Ryoke Japan 9 256 1.3× 115 1.9× 61 1.2× 41 0.9× 44 1.2× 14 371
Kenji Obata Japan 8 255 1.3× 41 0.7× 49 1.0× 55 1.1× 50 1.4× 10 327
W Musiał Poland 9 146 0.7× 66 1.1× 47 0.9× 24 0.5× 29 0.8× 28 271

Countries citing papers authored by L. E. Nimmo

Since Specialization
Citations

This map shows the geographic impact of L. E. Nimmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. Nimmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. Nimmo more than expected).

Fields of papers citing papers by L. E. Nimmo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. Nimmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. Nimmo. The network helps show where L. E. Nimmo may publish in the future.

Co-authorship network of co-authors of L. E. Nimmo

This figure shows the co-authorship network connecting the top 25 collaborators of L. E. Nimmo. A scholar is included among the top collaborators of L. E. Nimmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. E. Nimmo. L. E. Nimmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bloor, Colin M., et al.. (1997). Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. Molecular and Cellular Biochemistry. 176(1-2). 265–271. 12 indexed citations
2.
Bloor, Colin M., et al.. (1997). Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy. PubMed. 176(1-2). 265–271. 15 indexed citations
3.
Carroll, Susan M., L. E. Nimmo, Paul S. Knoepfler, F. C. White, & Colin M. Bloor. (1995). Gene Expression in a Swine Model of Right Ventricular Hypertrophy: Intercellular Adhesion Molecule, Vascular Endothelial Growth Factor and Plasminogen Activators are Upregulated during Pressure Overload. Journal of Molecular and Cellular Cardiology. 27(7). 1427–1441. 28 indexed citations
4.
Nakatani, Yosuke, et al.. (1992). Compensatory angiogenesis during progressive right ventricular hypertrophy.. PubMed. 4(1). 51–68. 19 indexed citations
5.
Breisch, Eric, F. C. White, L. E. Nimmo, & C. M. Bloor. (1986). Cardiac vasculature and flow during pressure-overload hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 251(5). H1031–H1037. 51 indexed citations
6.
Breisch, Eric, F. C. White, L. E. Nimmo, M. Dan McKirnan, & C. M. Bloor. (1986). Exercise-induced cardiac hypertrophy: a correlation of blood flow and microvasculature. Journal of Applied Physiology. 60(4). 1259–1267. 62 indexed citations
7.
Emara, Ashraf M., Leoš Landa, L. E. Nimmo, & Colin M. Bloor. (1978). Sarcolemmal permeability changes during early myocardial anoxia. Proceedings annual meeting Electron Microscopy Society of America. 36(2). 642–643. 1 indexed citations
8.
Crozatier, Bertrand, et al.. (1977). Sarcomere length in experimental myocardial infarction: Evidence for sarcomere overstretch in dyskinetic ventricular regions. Journal of Molecular and Cellular Cardiology. 9(10). 785–797. 39 indexed citations
9.
Ewy, Gordon A., Bertron Μ. Groves, Michael F. Ball, et al.. (1971). Digoxin Metabolism in Obesity. Circulation. 44(5). 810–814. 73 indexed citations
10.
Marcus, Gregory M., et al.. (1971). THE EFFECT OF ACUTE HYPOKALEMIA ON THE MYOCARDIAL CONCENTRATION AND BODY DISTRIBUTION OF TRITIATED DIGOXIN IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 178(2). 271–281. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026